Log in

RCi002-B

Donor information

Gender:Female

Disease status

Disease: Primary erythromelalgia
Affected: Yes
Disease variant
Chromosome location: 2q24.3
Zygosity: Heterozygous
Description: In the publication PMID:27099175, heterozygous point mutations were confirmed by Sanger sequencing: F1449V: TTC(F) >> GTG(V)

General information

Depositor:Pfizer Limited - Pfizer
Cell line name:RCi002-B
Cell line alternative names:FP5C-16, RCi93
Biosamples ID:SAMEA3106075
hPSCreg name:RCi002-B

Related lines

From the same donor: RCi002-A
At European Collection of Authenticated Cell Cultures (ECACC)
In stock
Cell Line Information Pack
A Cell Line Information Pack (CLIP) is created to communicate cell line specific information relating to restrictions on use to a user accessing cell lines from EBiSC. A CLIP contains information about a cell line including any specific third party obligations (TPOs) relating to, for example, intellectual property (IP) or the donor consent which affect the use of the cell line.